评估前列腺癌试验潜在参与者使用患者决策辅助工具的效用（RAVES-TROG 08.03）。
Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03).
机构信息
Department of Radiation Oncology, Royal Prince Alfred Hospital, Camperdown, Australia.
出版信息
Radiother Oncol. 2011 Dec;101(3):521-4. doi: 10.1016/j.radonc.2011.07.016. Epub 2011 Oct 8.
PMID:21985948
Abstract
Randomised controlled trials (RCTs) can be hampered by poor patient accrual and retention. Decision aids (DAs) containing simple, evidence-based information, may assist patients with decision-making regarding trial participation. The current DA was of use for 95% of participants. Further evaluation of the DA in a RCT is currently underway.
摘要
随机对照试验 (RCT) 可能会因患者入组和保留率低而受到阻碍。包含简单、基于证据的信息的决策辅助 (DA) 可以帮助患者做出关于参与试验的决策。当前的 DA 对 95%的参与者有用。目前正在对 RCT 中的 DA 进行进一步评估。
Zotero 插件